Outlook Therapeutics (OTLK) Other Working Capital Changes (2015 - 2026)
Outlook Therapeutics (OTLK) reported Other Working Capital Changes of $5000.0 for Q1 2026, down 80.56% year-over-year from $25716.0 in Q1 2025, and up 137.04% quarter-over-quarter from -$13499.0 in Q4 2025.
Outlook Therapeutics (OTLK) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has 12 years of Other Working Capital Changes data on file, last reported at $5000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $5000.0, down 80.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $5000.0 (down 80.56% YoY), and the FY2025 annual result was $25716.0, up 166.63% from the prior year.
- Other Working Capital Changes climbed to $5000.0 in Q1 2026 per OTLK's latest filing, from -$13499.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $4.9 million in Q3 2024 and troughed at -$1.8 million in Q3 2025.
- A 5-year average of $171024.0 and a median of $5000.0 in 2026 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 410.12% in 2023 and fell as far as 15868.61% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at -$788509.0 in 2022, then jumped by 410.12% to $2.4 million in 2023, then slumped by 100.49% to -$12071.0 in 2024, then retreated by 11.83% to -$13499.0 in 2025, then jumped by 137.04% to $5000.0 in 2026.
- Business Quant data shows OTLK's Other Working Capital Changes at $5000.0 in Q1 2026, -$13499.0 in Q4 2025, and -$1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | -13,499.00 |
| Dec 31, 2025 | -13,499.00 |
| Sep 30, 2025 | -1.84 Mn |
| Sep 30, 2025 | -1.84 Mn |
| Jun 30, 2025 | 25,716.00 |
| Jun 30, 2025 | 25,716.00 |
| Mar 31, 2025 | 25,716.00 |
| Mar 31, 2025 | 25,716.00 |
| Dec 31, 2024 | -12,071.00 |
| Dec 31, 2024 | -12,071.00 |
| Sep 30, 2024 | 4.90 Mn |
| Sep 30, 2024 | 4.90 Mn |
| Jun 30, 2024 | 9,645.00 |
| Jun 30, 2024 | 9,645.00 |
| Mar 31, 2024 | 8,333.00 |
| Mar 31, 2024 | 8,333.00 |
| Dec 31, 2023 | 2.45 Mn |
| Dec 31, 2023 | 2.45 Mn |